Wilbanks Smith & Thomas Asset Management LLC Galapagos Nv Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$87.81 - $110.65 $878 - $1,106	-10 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$90.63 - $120.22 $906 - $1,202	10 New	10 $1,000

Others Institutions Holding GLPG

# of Institutions

Shares Held

17.4M

Call Options Held

10.4K

Put Options Held

33.1K

Eco R1 Capital, LLC San Francisco, CA

5.76M
Shares

$159 Million
5.04% of portfolio
Bvf Inc San Francisco, CA

1.57M
Shares

$43.3 Million
1.19% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

1.41M
Shares

$38.9 Million
0.73% of portfolio
Prosight Management, LP Dallas, TX

1.35M
Shares

$37.2 Million
10.45% of portfolio
Segall Bryant & Hamill, LLC Chicago, IL

799K
Shares

$22 Million
0.36% of portfolio

View Full List

About GALAPAGOS NV

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.82B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

More about GLPG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account